These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Hemorrhage into the peritoneum in the course of treatment of adrenocortical carcinoma with o,p'-DDD and 5-fluorouracil]. Kasperlik-Zaluska A; Migdalska B Endokrynol Pol; 1976; 27(1):111-5. PubMed ID: 1253752 [No Abstract] [Full Text] [Related]
4. Adrenal cortical carcinoma: a case report. Judy JC; Scardino PL J Med Assoc Ga; 1973 Nov; 62(11):377-9. PubMed ID: 4128251 [No Abstract] [Full Text] [Related]
5. Mitotane use in inoperable adrenal cortical carcinoma. Lubitz JA; Freeman L; Okun R JAMA; 1973 Mar; 223(10):1109-12. PubMed ID: 4739370 [No Abstract] [Full Text] [Related]
6. Regression of an adrenal cortical carcinoma and its neovascular bed following mitotane therapy: a case report. Downing V; Eule J; Huseby RA Cancer; 1974 Dec; 34(6):1882-7. PubMed ID: 4434322 [No Abstract] [Full Text] [Related]
7. Adrenal gland: Cancer target of mitotane identified. Holmes D Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26370730 [No Abstract] [Full Text] [Related]
8. [Does Op'DDD possess an antimitotic action? Remarks apropos of its use in the treatment of adrenal adenocarcinomas]. Bricaire H; Luton JP Nouv Presse Med; 1977 Nov; 6(39):3650. PubMed ID: 607185 [No Abstract] [Full Text] [Related]
9. Drug treatment of inoperable adrenocortical carcinoma. Metz SA JAMA; 1973 Apr; 224(4):530. PubMed ID: 4739624 [No Abstract] [Full Text] [Related]
10. Mitotane administration: an unusual cause of hypercholesterolemia. Vassilopoulou-Sellin R; Samaan NA Horm Metab Res; 1991 Dec; 23(12):619-20. PubMed ID: 1778600 [No Abstract] [Full Text] [Related]
11. [Adrenocortical cancer in children]. Loredo Abdalá A; Martínez Guerra G; Delgado Gallardo S Bol Med Hosp Infant Mex; 1981; 38(1):209-11. PubMed ID: 7284069 [No Abstract] [Full Text] [Related]
12. [Malignant adrenal carcinoma with metastases: exeresis and treatment with op'DD followed by cure]. Rappaport R; Schweisguth O; Cachin O; Pellerin D Arch Fr Pediatr; 1978 May; 35(5):551-4. PubMed ID: 678033 [TBL] [Abstract][Full Text] [Related]
13. Late recurrence of operated adrenocortical carcinoma: atrial natriuretic factor before and after treatment with mitotane. Donckier JE; Michel LA; Berbinschi A; De Coster PM; De Plaen JF; Ketelslegers JM; Buysschaert M Surgery; 1989 May; 105(5):690-2. PubMed ID: 2523092 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of Cushing's syndrome and adrenal cancer with O,p-DDD]. Kinouchi T; Shimizu N; Ibayashi H; Demura H; Oshima H Horumon To Rinsho; 1982 Aug; 30(8):841-51. PubMed ID: 7139984 [No Abstract] [Full Text] [Related]
16. A young woman with a severe bilateral pneumonia as the presenting sign of an adrenal carcinoma. Chamuleau SA; Corssmit EP; Pereira AM; van de Berg BT; Siegert CE Neth J Med; 2008 Mar; 66(3):121-4. PubMed ID: 18349468 [TBL] [Abstract][Full Text] [Related]
18. Effect of suramin in a patient with adrenocortical carcinoma. Vierhapper H; Nowotny ; Mostbeck G; Waldhäusl W Lancet; 1989 May; 1(8648):1207-8. PubMed ID: 2566771 [No Abstract] [Full Text] [Related]
19. A case of adrenal gland dependent hyperadrenocorticism with mitotane therapy in a Yorkshire terrier dog. Lee YM; Kang BT; Jung DI; Park C; Kim HJ; Kim JW; Lim CY; Park EH; Park HM J Vet Sci; 2005 Dec; 6(4):363-6. PubMed ID: 16294004 [TBL] [Abstract][Full Text] [Related]